Drugplain

UNBLEMISH Dual Intensive Acne Treatment .025 g/mL

BENZOYL PEROXIDE · LOTION · Rodan & Fields

No Recall HistoryCurrently in Shortage
Plain English

UNBLEMISH Dual Intensive Acne Treatment is a lotion containing benzoyl peroxide at .025 g/mL, taken topical. Manufactured by Rodan & Fields.

Key Facts

Brand Name
UNBLEMISH Dual Intensive Acne Treatment
Generic Name
BENZOYL PEROXIDE
NDC Code (Product)
14222-2120
Manufacturer
Rodan & Fields
Strength
.025 g/mL
Dosage Form
LOTION
Route
TOPICAL
Marketing Status
Application #
M006
Marketing Start
02/13/2019

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

drug ineffective137 reports
rash88 reports
erythema69 reports
pain65 reports
pruritus64 reports
off label use63 reports
fatigue61 reports
nausea61 reports
anxiety60 reports
acne54 reports

Frequently Asked Questions

What is UNBLEMISH Dual Intensive Acne Treatment used for?

UNBLEMISH Dual Intensive Acne Treatment contains BENZOYL PEROXIDE. It is a lotion taken topical. Consult your doctor for specific uses.

Is UNBLEMISH Dual Intensive Acne Treatment a controlled substance?

UNBLEMISH Dual Intensive Acne Treatment is not classified as a controlled substance by the DEA.

What is the generic name for UNBLEMISH Dual Intensive Acne Treatment?

The generic name for UNBLEMISH Dual Intensive Acne Treatment is BENZOYL PEROXIDE. There are 12 other brand versions of BENZOYL PEROXIDE.

What is the NDC code for UNBLEMISH Dual Intensive Acne Treatment .025 g/mL?

The NDC (National Drug Code) for UNBLEMISH Dual Intensive Acne Treatment .025 g/mL is 14222-2120, listed by Rodan & Fields.

Product NDC

14222-2120

Package NDC

14222-2120-1

Other Benzoyl Brands

See all →

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)